Literature DB >> 8900440

Identification of arachidonic acid pathways required for the invasive and metastatic activity of malignant tumor cells.

R Reich1, G R Martin.   

Abstract

Metastasis is a complex process, almost a cascade, involving multiple steps and activities. However, an important factor is that malignant cells are able to penetrate through the multiple basement membrane barriers surrounding tissues, blood vessels, nerves and muscle that would otherwise block their dissemination. Penetration of malignant tumor cells through basement membrane is an active process requiring proteolysis. We report here that inhibitors of both the cyclooxygenase and lipoxygenase pathways of arachidonic acid metabolism convert mouse melanoma and human fibrosarcoma cells to a non invasive state by reducing the production of MMP-2, an enzyme required for the degradation of basement membranes. Specific metabolites of each pathway, i.e. PGF2 alpha and 5-HPETE, are able to transcend the block and restore collagenase production, invasiveness in vitro and metastatic activity in vivo. These studies indicate a key role for arachidonic acid metabolites in metastasis and suggest novel therapeutic approaches for inhibiting the spread of cancer.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8900440     DOI: 10.1016/0090-6980(95)00154-9

Source DB:  PubMed          Journal:  Prostaglandins        ISSN: 0090-6980


  18 in total

Review 1.  Drug development against metastasis-related genes and their pathways: a rationale for cancer therapy.

Authors:  Megumi Iiizumi; Wen Liu; Sudha K Pai; Eiji Furuta; Kounosuke Watabe
Journal:  Biochim Biophys Acta       Date:  2008-07-22

2.  Anti-inflammatory agent indomethacin reduces invasion and alters metabolism in a human breast cancer cell line.

Authors:  Ellen Ackerstaff; Barjor Gimi; Dmitri Artemov; Zaver M Bhujwalla
Journal:  Neoplasia       Date:  2007-03       Impact factor: 5.715

3.  Dose-dependent inhibition of cell proliferation induced by lipid peroxidation products in rat hepatoma cells after enrichment with arachidonic acid.

Authors:  G Muzio; R A Salvo; A Trombetta; R Autelli; M Maggiora; M Terreno; M U Dianzani; R A Canuto
Journal:  Lipids       Date:  1999-07       Impact factor: 1.880

4.  Reduction of COX-2 through modulating miR-124/SPHK1 axis contributes to the antimetastatic effect of alpinumisoflavone in melanoma.

Authors:  Ming Gao; Yuan Chang; Xiuyong Wang; Chao Ban; Fan Zhang
Journal:  Am J Transl Res       Date:  2017-03-15       Impact factor: 4.060

5.  Control of pulmonary metastases of rat mammary cancer by inhibition of uPA and COX-2, singly and in combination.

Authors:  Douglas M Evans; Kimberly D Sloan Stakleff
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

6.  Clinicopathologic association of cyclooxygenase 1 and cyclooxygenase 2 expression in gastric adenocarcinoma.

Authors:  C N Chen; C T Sung; M T Lin; P H Lee; K J Chang
Journal:  Ann Surg       Date:  2001-02       Impact factor: 12.969

7.  Effects of Celebrex and Zyflo on liver metastasis and lipidperoxidation in pancreatic cancer in Syrian hamsters.

Authors:  F A Wenger; M Kilian; M Bisevac; C Khodadayan; M von Seebach; I Schimke; H Guski; J M Müller
Journal:  Clin Exp Metastasis       Date:  2002       Impact factor: 5.150

8.  Collagenase-3 induction in rat lung fibroblasts requires the combined effects of tumor necrosis factor-alpha and 12-lipoxygenase metabolites: a model of macrophage-induced, fibroblast-driven extracellular matrix remodeling during inflammatory lung injury.

Authors:  T J Mariani; S Sandefur; J D Roby; R A Pierce
Journal:  Mol Biol Cell       Date:  1998-06       Impact factor: 4.138

9.  Requirement of cyclooxygenase-2 expression and prostaglandins for human prostate cancer cell invasion.

Authors:  Kasem Nithipatikom; Marilyn A Isbell; Paul F Lindholm; Andre Kajdacsy-Balla; Sushma Kaul; William B Campell
Journal:  Clin Exp Metastasis       Date:  2002       Impact factor: 5.150

10.  Exposure of human breast cancer cells to the anti-inflammatory agent indomethacin alters choline phospholipid metabolites and Nm23 expression.

Authors:  Kshama Natarajan; Noriko Mori; Dmitri Artemov; Zaver M Bhujwalla
Journal:  Neoplasia       Date:  2002 Sep-Oct       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.